UnitedHealth Group Incorporated $UNH Stock: State of Alaska Department of Revenue Trims Holdings

State of Alaska Department of Revenue decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,794 shares of the healthcare conglomerate’s stock after selling 3,952 shares during the period. State of Alaska Department of Revenue’s holdings in UnitedHealth Group were worth $38,100,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of UNH. Ninety One North America Inc. increased its position in shares of UnitedHealth Group by 24.8% during the 3rd quarter. Ninety One North America Inc. now owns 14,374 shares of the healthcare conglomerate’s stock worth $5,276,000 after purchasing an additional 2,856 shares during the last quarter. WealthPlan Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 12.9% in the 3rd quarter. WealthPlan Investment Management LLC now owns 21,049 shares of the healthcare conglomerate’s stock valued at $7,727,000 after buying an additional 2,400 shares during the last quarter. Purus Wealth Management LLC grew its stake in shares of UnitedHealth Group by 16.7% in the third quarter. Purus Wealth Management LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $300,000 after buying an additional 117 shares in the last quarter. SBE LLC DBA Cedar Cove Wealth Partners grew its stake in shares of UnitedHealth Group by 2.4% in the third quarter. SBE LLC DBA Cedar Cove Wealth Partners now owns 1,306 shares of the healthcare conglomerate’s stock valued at $480,000 after buying an additional 31 shares in the last quarter. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors increased its holdings in UnitedHealth Group by 40.6% during the third quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 1,645 shares of the healthcare conglomerate’s stock worth $604,000 after buying an additional 475 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings beat and raised guidance: UnitedHealth reported third-quarter revenue of $112.7 billion and adjusted EPS of $4.69, exceeding consensus estimates. Management raised its 2026 adjusted EPS outlook to at least $20.50, above the prior range and analyst expectations. UnitedHealth Group gains after Q3 beat and higher 2026 outlook
• Positive Sentiment: Margin recovery is improving: The medical care ratio improved to 88.4%, while better cost management, pricing discipline and benefit changes supported profitability. Goldman Sachs said Medicare Advantage margins are recovering faster than expected, and UnitedHealth described 2026 as a potential bottom for Medicaid margins. Goldman Sachs report on UNH earnings and margin recovery
• Positive Sentiment: 2027 growth prospects attract bullish analyst views: Management highlighted a potential return to stronger growth, including 13%–16% long-term earnings growth, special-needs Medicare plans, expanded coverage and AI tools that reduce administrative work. Goldman Sachs raised its price target to $506, while Piper Sandler maintained an overweight rating with a $504 target. Can UNH’s focus on special needs plans strengthen Medicare growth?
• Neutral Sentiment: Analyst views remain divided: Piper Sandler and Goldman Sachs see substantial upside, but TD Cowen reaffirmed a hold rating with a $402 target. Barclays and Robert W. Baird also reduced their targets, reflecting uncertainty about the pace of recovery.
• Negative Sentiment: Growth risks remain: Revenue was essentially flat year over year, membership has declined, and investors continue to question the company’s growth path. Commercial medical costs and Medicaid pressure could delay broader margin recovery, leaving some analysts concerned that the recent earnings positives are already reflected in the valuation. UnitedHealth beats on earnings, but investors question growth path

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Leerink Partners lifted their price target on UnitedHealth Group from $462.00 to $472.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Barclays dropped their price objective on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Wall Street Zen raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $461.48.

Insiders Place Their Bets

In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $14.91 during mid-day trading on Thursday, reaching $410.53. 5,614,979 shares of the company were exchanged, compared to its average volume of 7,369,734. The stock has a market capitalization of $368.49 billion, a P/E ratio of 23.43, a P/E/G ratio of 1.41 and a beta of 0.60. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The company’s 50-day simple moving average is $387.10 and its 200-day simple moving average is $383.47. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The business had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. UnitedHealth Group’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 20.00 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.